Goldman Sachs has promoted several new executives for its major business lines, reflecting a shift in leadership. Among these ...
The companies have worked together in the logistics real estate sector since 2020, focusing on last-mile industrial ...
Goldman Sachs analyst Louise Singlehurst maintained a Hold rating on Dr. Martens Plc (DOCS – Research Report) yesterday and set a price target of p69.00. The company’s shares closed yesterday ...
Dr Agarwal’s Healthcare allotted 2.17 crore equity shares to 43 funds at ₹402 apiece, which is also the upper end of the ...
Dr Agarwals Health Care secures Rs 875.5 crore from anchor investors, including major firms, ahead of its IPO set for9-31.
It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...
TL;DR: Goldman Sachs updated its 2027 estimates for Tesla, predicting the robotaxi business will start in late 2026, generating $115 million in revenue by 2027. The firm expects Tesla to use ...
Brokerages have reacted to the third-quarter financial results of UltraTech Cement Ltd., Dr. Reddy's Ltd. and Hindustan Petroleum Corporation Ltd. UltraTech remains a strong pick due to its solid ...